[
  {
    "ts": null,
    "headline": "Eli Lilly Q4: Don't Miss Out On 2025 Gains, There's Limited Space Left",
    "summary": "Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and pricing challenges loom. See more here.",
    "url": "https://finnhub.io/api/news?id=3034fc1c618b515fa749d36cbda51fe57b5acd6b4b6b98831319c66a405452c8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738879930,
      "headline": "Eli Lilly Q4: Don't Miss Out On 2025 Gains, There's Limited Space Left",
      "id": 132595860,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2068074488/image_2068074488.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and pricing challenges loom. See more here.",
      "url": "https://finnhub.io/api/news?id=3034fc1c618b515fa749d36cbda51fe57b5acd6b4b6b98831319c66a405452c8"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Climbs After Lilly Earnings - Health Care Roundup",
    "summary": "Health Care Climbs After Lilly Earnings - Health Care Roundup",
    "url": "https://finnhub.io/api/news?id=c5fe41566f9469ac1656783a3ad4e9285f9be807077deda0c5c1d091e7e7b209",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738862460,
      "headline": "Health Care Climbs After Lilly Earnings - Health Care Roundup",
      "id": 132584274,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Health Care Climbs After Lilly Earnings - Health Care Roundup",
      "url": "https://finnhub.io/api/news?id=c5fe41566f9469ac1656783a3ad4e9285f9be807077deda0c5c1d091e7e7b209"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Stock Has Surged. Here’s Where It’s Headed Next.",
    "summary": "Amgen Stock Has Surged. Here’s Where It’s Headed Next.",
    "url": "https://finnhub.io/api/news?id=ad5b172ec4ba2f3a6e56b0ff80084faf18034c4cc6c82f439cdb65ce7fd76f04",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738858620,
      "headline": "Amgen Stock Has Surged. Here’s Where It’s Headed Next.",
      "id": 132581121,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Amgen Stock Has Surged. Here’s Where It’s Headed Next.",
      "url": "https://finnhub.io/api/news?id=ad5b172ec4ba2f3a6e56b0ff80084faf18034c4cc6c82f439cdb65ce7fd76f04"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Q4 Earnings: Now The Magical $1 Trillion Dollar Market Cap Is In Sight",
    "summary": "Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline. Click for my LLY stock update.",
    "url": "https://finnhub.io/api/news?id=dd17313f5bed105c7779521cff776d564d6fc8881080b01cb6fba4fc4acd9d37",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738856271,
      "headline": "Eli Lilly Q4 Earnings: Now The Magical $1 Trillion Dollar Market Cap Is In Sight",
      "id": 132580513,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/521503314/image_521503314.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline. Click for my LLY stock update.",
      "url": "https://finnhub.io/api/news?id=dd17313f5bed105c7779521cff776d564d6fc8881080b01cb6fba4fc4acd9d37"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly and Company (LLY) Q4 2024 Earnings Call Transcript",
    "summary": "Eli Lilly and Company (NYSE:LLY) Q4 2024 Results Conference Call February 6, 2025 10:00 AM ETCompany ParticipantsMike Czapar - Senior Vice President of...",
    "url": "https://finnhub.io/api/news?id=2bbed3aba2f6028881ddbdb446d817f73f824c1f7863b5e62f3517c0bf854352",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738851786,
      "headline": "Eli Lilly and Company (LLY) Q4 2024 Earnings Call Transcript",
      "id": 132580335,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Eli Lilly and Company (NYSE:LLY) Q4 2024 Results Conference Call February 6, 2025 10:00 AM ETCompany ParticipantsMike Czapar - Senior Vice President of...",
      "url": "https://finnhub.io/api/news?id=2bbed3aba2f6028881ddbdb446d817f73f824c1f7863b5e62f3517c0bf854352"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Lunch: U.S. Could Ban DeepSeek On Government Devices",
    "summary": "U.S. House lawmakers plan to introduce legislation to ban DeepSeekâs app from government-issued devices",
    "url": "https://finnhub.io/api/news?id=52c0edb28fc34aa317f78d7eeff2b1561ea2f66878303c9208092972da50a46c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738850040,
      "headline": "Wall Street Lunch: U.S. Could Ban DeepSeek On Government Devices",
      "id": 132579821,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2196139559/image_2196139559.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "U.S. House lawmakers plan to introduce legislation to ban DeepSeekâs app from government-issued devices",
      "url": "https://finnhub.io/api/news?id=52c0edb28fc34aa317f78d7eeff2b1561ea2f66878303c9208092972da50a46c"
    }
  },
  {
    "ts": null,
    "headline": "The Obesity Market Is Growing Just Fine. But Investors Want to Know What’s Next",
    "summary": "The Obesity Market Is Growing Just Fine. But Investors Want to Know What’s Next",
    "url": "https://finnhub.io/api/news?id=932a8091c46bf2f2398034511185cc5419ae569cb1700376c0fd36882827cb1c",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738840560,
      "headline": "The Obesity Market Is Growing Just Fine. But Investors Want to Know What’s Next",
      "id": 132573816,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "The Obesity Market Is Growing Just Fine. But Investors Want to Know What’s Next",
      "url": "https://finnhub.io/api/news?id=932a8091c46bf2f2398034511185cc5419ae569cb1700376c0fd36882827cb1c"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market Today: Dow Jones Flat But Nvidia Rises On DeepSeek News; Cathie Wood Stock Crashes (Live Coverage)",
    "summary": "Stock Market Today: Dow Jones Flat But Nvidia Rises On DeepSeek News; Cathie Wood Stock Crashes (Live Coverage)",
    "url": "https://finnhub.io/api/news?id=4f8817b76f78c0f85ed69c5388ff1b323b7de624b01d97dfdc7b7a1d0b12dc96",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738838969,
      "headline": "Stock Market Today: Dow Jones Flat But Nvidia Rises On DeepSeek News; Cathie Wood Stock Crashes (Live Coverage)",
      "id": 132573497,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "Stock Market Today: Dow Jones Flat But Nvidia Rises On DeepSeek News; Cathie Wood Stock Crashes (Live Coverage)",
      "url": "https://finnhub.io/api/news?id=4f8817b76f78c0f85ed69c5388ff1b323b7de624b01d97dfdc7b7a1d0b12dc96"
    }
  },
  {
    "ts": null,
    "headline": "Lilly’s Mounjaro and Zepbound contribute to big revenue boost, drugmaker says",
    "summary": "Lilly’s Mounjaro and Zepbound contribute to big revenue boost, drugmaker says",
    "url": "https://finnhub.io/api/news?id=92f4446adb902d632cc07cc34f203a7ec4a2b2b2a7b3a5ec21121a6df458b4ac",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738838160,
      "headline": "Lilly’s Mounjaro and Zepbound contribute to big revenue boost, drugmaker says",
      "id": 132573836,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Lilly’s Mounjaro and Zepbound contribute to big revenue boost, drugmaker says",
      "url": "https://finnhub.io/api/news?id=92f4446adb902d632cc07cc34f203a7ec4a2b2b2a7b3a5ec21121a6df458b4ac"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Jumps, Reversing Its Weight-Loss Setback, On A Strong 2025 Outlook",
    "summary": "Eli Lilly Jumps, Reversing Its Weight-Loss Setback, On A Strong 2025 Outlook",
    "url": "https://finnhub.io/api/news?id=4d5b78d2c9738f17c9d023ae94d11691abc7dd7dec2c41b05cc5a2ac01ba9ba3",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738836983,
      "headline": "Eli Lilly Jumps, Reversing Its Weight-Loss Setback, On A Strong 2025 Outlook",
      "id": 132573818,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "Eli Lilly Jumps, Reversing Its Weight-Loss Setback, On A Strong 2025 Outlook",
      "url": "https://finnhub.io/api/news?id=4d5b78d2c9738f17c9d023ae94d11691abc7dd7dec2c41b05cc5a2ac01ba9ba3"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly’s Disappointing Quarter Was Already Baked In",
    "summary": "Eli Lilly’s Disappointing Quarter Was Already Baked In",
    "url": "https://finnhub.io/api/news?id=606448580ac87a1921e423bb43db271af988ec8cb850cd17aab682c2e81c1426",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738835760,
      "headline": "Eli Lilly’s Disappointing Quarter Was Already Baked In",
      "id": 132573837,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Eli Lilly’s Disappointing Quarter Was Already Baked In",
      "url": "https://finnhub.io/api/news?id=606448580ac87a1921e423bb43db271af988ec8cb850cd17aab682c2e81c1426"
    }
  },
  {
    "ts": null,
    "headline": "Viking Therapeutics Plummeted 8% On Its Earnings Report. Here's Why.",
    "summary": "Viking Therapeutics Plummeted 8% On Its Earnings Report. Here's Why.",
    "url": "https://finnhub.io/api/news?id=6ba2a124afc443124de8f8f1e8012e71995ef308ec167dfb1ee99ab7210b098d",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738833277,
      "headline": "Viking Therapeutics Plummeted 8% On Its Earnings Report. Here's Why.",
      "id": 132573819,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "Viking Therapeutics Plummeted 8% On Its Earnings Report. Here's Why.",
      "url": "https://finnhub.io/api/news?id=6ba2a124afc443124de8f8f1e8012e71995ef308ec167dfb1ee99ab7210b098d"
    }
  }
]